Because ADHD symptoms overlap with other diagnoses, it may be difficult for clinicians to determine if ADHD is the primary cause, ADHD symptoms are secondary to other diagnoses, or ADHD is simply comorbid with other diagnoses. The NEBA System includes a method to integrate an EEG biomarker for ADHD (standardized theta/beta ratio) with a clinician’s ADHD evaluation to help determine whether ADHD is the primary diagnosis. Investigators conducted a triple-blinded, multi- site, clinical cohort investigation to demonstrate whether NEBA would augment a clinician’s ADHD evaluation.
NEBA Health Key Results Summary
July 22, 2013